Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial

What Was Tested

This randomized controlled trial paper looks at hCG (human chorionic gonadotropin) and Buserelin in the context of endometriosis.

Who Took Part

According to the abstract, 18 women were involved.

PubMed indexes the participants as adults, women only.

Thirty-five women were randomly allocated to buserelin treatment and 36 to expectant management.

The baseline distribution of subjects for age, disease stage, and reproductive history was similar in the two groups.

How the Study Was Run

The design is described as randomized.

Because people in this hCG (human chorionic gonadotropin) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

The timeline in the abstract includes 12 months.

All patients were followed regularly; median follow-up was 17 months in the buserelin group and 18 months in the women given expectant management.

If pregnancy did not occur within 12 months of randomization, cycles were monitored by ultrasonography and hormone measurements, and when abnormalities were detected clomiphene citrate and human chorionic gonadotropin were administered.

What Was Measured

The subject headings attached to it are Buserelin, Chorionic Gonadotropin, Clomiphene, Endometriosis, Infertility, Female and Ovulation Induction.

What This Means in Plain Language

The paper is a randomized study of hCG (human chorionic gonadotropin) and Buserelin in 18 women in people with endometriosis over 12 months.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 1992 (American journal of obstetrics and gynecology), a journal based in United States.

More context: the hCG (human chorionic gonadotropin) compound page and the Buserelin compound page, Endometriosis research.